| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | -0.076 | 0.2 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | 0.053 | 0.2 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.2 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | JQ-1 | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |